(97 days)
The InnerVue™ Diagnostic Scope System is indicated for use in diagnostic and operative arthroscopic and endoscopic procedures to provide illumination and visualization of an interior cavity of the body through either a natural or surgical opening. Examples of generic surgical use include the visualization of joints within the body. These joints can include, joints located in the torso/trunk, upper/lower extremities, and the temporomandibular joint.
The InnerVue™ Diagnostic Scope System consists of five (5) main parts: hardware, software, instrumentation and procedural kit(s).
Hardware: The hardware consists of the following components: Monitor, keyboard, image processor, Xenon light source, camera unit, power supply, printer, handpiece (which incorporates the camera head and light cable), a slide-out working surface and a storage drawer.
Software: The software enhances the image from the scope to remove fiber optic pixilation without adding distortion. The software allows the operator to record and print still images as well as record and archive audio and video information recorded during the procedure.
Scope: A rigid fiber optic scope designed for one-time use.
Supplementary Instruments: Supplementary instruments consist of four (4) pieces that can be used interchangeably throughout the procedure. The four components are a cannula, a trocar, and a cannula plug. Both disposable supplementary instruments are available with the system.
Procedural Kits: Supplementary items to assist in the surgical procedure.
The provided text states, "Clinical Testing: None provided as a basis for substantial equivalence." This means that no clinical study was conducted to prove the device meets acceptance criteria specific to its diagnostic or operational performance related to medical outcomes.
Instead, the device's substantial equivalence and performance are based on compliance with electrical safety and general medical equipment standards.
Here's the breakdown of the information requested, based on the provided text:
1. A table of acceptance criteria and the reported device performance
| Acceptance Criteria (from text) | Reported Device Performance (from text) |
|---|---|
| Compliance with Can/CSA C22.2 No 601.1-M90 | The InnerVue™ Diagnostic Scope System complies with this standard. |
| Compliance with CSA 601.1 Supplement 1:1994 | The InnerVue™ Diagnostic Scope System complies with this standard. |
| Compliance with CSA 601.1 Amendment 2:1998 | The InnerVue™ Diagnostic Scope System complies with this standard. |
| Compliance with CAN/CSA C22.2 No. 60601-2-18-01 | The InnerVue™ Diagnostic Scope System complies with this standard. |
| Compliance with UL Std No 60601-1 (1st Edition) | The InnerVue™ Diagnostic Scope System complies with this standard. |
| Compliance with IEC 60601-2-18 (1996) 2nd Edition | The InnerVue™ Diagnostic Scope System complies with this standard. |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
Not applicable. No clinical testing with a test set was conducted for substantial equivalence. The performance assessment was based on compliance with electrical and safety standards, not clinical data or patient samples.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
Not applicable. No clinical testing was performed, so no experts were used to establish ground truth for a test set.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable. No clinical testing was performed.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. No MRMC study was mentioned or conducted, as the device is not an AI-assisted diagnostic tool and no clinical testing was performed for substantial equivalence.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. No standalone algorithm performance was assessed as this is a medical device for visualization and illumination, not an AI or algorithm-based diagnostic tool. The performance was assessed against safety and electrical standards.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
Not applicable. Ground truth in a clinical sense was not established as no clinical testing was performed. The "ground truth" for compliance was the requirements outlined in the specified electrical and medical device safety standards.
8. The sample size for the training set
Not applicable. No training set was used as this device does not involve machine learning or AI that requires a training set.
9. How the ground truth for the training set was established
Not applicable. No training set was used.
{0}------------------------------------------------
- 1 e.t 2
BIOMET
INC.
510(k) Summary InnerVue™ Diagnostic Scope System
| Preparation Date: | December 20, 2007 | JAN 1 4 2008 |
|---|---|---|
| Applicant/Sponsor: | Biomet Sports Medicine56 East Bell DriveWarsaw, Indiana 46582 | |
| Contact Person: | Susan AlexanderRegulatory Affairs Specialist | |
| Proprietary Name: | InnerVue™ Diagnostic Scope System | |
| Common Name: | Arthroscope, endoscope | |
| Classification Name: | Arthroscope, 21 CFR §888.1100, HRXEndoscope, 21 CFR §876.1500, GCJ |
Legally Marketed Devices To Which Substantial Equivalence Is Claimed:
| Video Arthroscope | K043395 | Smith & Nephew |
|---|---|---|
| InnerVue™ Diagnostic Scope System | K040604 | Arthrotek, Inc. (Biomet Sports Medicine) |
| Arthrex Arthroscopes | K030096 | Arthrex, Inc. |
| METRx™ System | K002931 | Medtronic Sofamor Danek |
| Integrated Endoscopy System | K920800 | Integrated Endoscopy System |
Device Description: The InnerVue™ Diagnostic Scope System consists of five (5) main parts: hardware, software, instrumentation and procedural kit(s).
Hardware: The hardware consists of the following components: Monitor, keyboard, image processor, Xenon light source, camera unit, power supply, printer, handpiece (which incorporates the camera head and light cable), a slide-out working surface and a storage drawer.
Software: The software enhances the image from the scope to remove fiber optic pixilation without adding distortion. The software allows the operator to record and print still images as well as record and archive audio and video information recorded during the procedure.
Scope: A rigid fiber optic scope designed for one-time use.
Supplementary Instruments: Supplementary instruments consist of four (4) pieces that can be used interchangeably throughout the procedure. The four components are a cannula, a trocar, and a cannula plug. Both disposable supplementary instruments are available with the system.
Procedural Kits: Supplementary items to assist in the surgical procedure.
Clinical Testing: None provided as a basis for substantial equivalence.
Mailing Address: PO Box 587 Warsaw, IN 46581-0587 Toll Free: 800,348,9500 Office: 574.267.6639 Main Fax: 574.267.8137 www.biomet.com
Shipping Address: 56 Fast Roll Drive Warsaw, IN 46582
{1}------------------------------------------------
072879
: 01 2
Indications for Use: The InnerVue™ Diagnostic Scope System is indicated for use in diagnostic and operative arthroscopic and endoscopic procedures to provide illumination and visualization of an interior cavity of the body through either a natural or surgical opening. Examples of generic surgical use include the visualization of joints within the body. These joints can include, joints located in the torso/trunk, upper/lower extremities, and the temporomandibular joint.
Summary of Technologies: The technological characteristics of the InnerVue™ Diagnostic Scope System are the same as, or similar to, the predicate devices.
Performance and Safety Testing
The InnerVue™ Diagnostic Scope System complies with Can/CSA C22.2 No 601.1-M90 - Safety of Medical Electrical Equipment, part 1., General; CSA 601.1 Supplement 1:1994 - Requirements for Safety, CSA 601.1 Amendment 2:1998, CAN/CSA C22.2 No. 60601-2-18-01 - Particular Requirements for the Safety of Endoscopic Equipment, UL Std No 60601-1(1st Edition) - Safety of Medical Equipment , Part I: General Requirements for Safety and IEC 60601-2-18(1996) 2nd Edition.
{2}------------------------------------------------
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized emblem featuring a symbol that resembles an abstract human form or a caduceus, rendered in black.
Public Health Service
JAN 1 4 2008
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Biomet Manufacturing Corp. % Ms. Susan Alexander Regulatory Affairs Specialist P.O. Box 587 Warsaw, Indiana 46581-0587
Re: K072879
Trade/Device Name: InnerVue™ Diagnostic Scope System Regulation Number: 21 CFR 888.1100 Regulation Name: Arthroscope Regulatory Class: II Product Code: HRX Dated: December 20, 2007 Received: December 21, 2007
Dear Ms. Alexander:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
{3}------------------------------------------------
Page 2 - Ms. Susan Alexander
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance. please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours.
Mark N Millman
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
Indications for Use
510(k) Number (if known):_
Device Name: InnerVue™ Diagnostic Scope System
Indications for Use:
The InnerVue™ Diagnostic Scope System is indicated for use in diagnostic and operative arthroscopic and endoscopic procedures to provide illumination and visualization of an interior cavity of the body through either a natural or surgical opening. Examples of generic surgical use include the visualization of joints within the body. These joints can include, joints located in the torso/trunk, upper/lower extremities, and the temporomandibular joint.
Prescription Use YES (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use _ NO (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page 1 of 1
State bill Be Division of Ge and Neurologica
510 Number 16072875
§ 888.1100 Arthroscope.
(a)
Identification. An arthroscope is an electrically powered endoscope intended to make visible the interior of a joint. The arthroscope and accessories also is intended to perform surgery within a joint.(b)
Classification. (1) Class II (performance standards).(2) Class I for the following manual arthroscopic instruments: cannulas, currettes, drill guides, forceps, gouges, graspers, knives, obturators, osteotomes, probes, punches, rasps, retractors, rongeurs, suture passers, suture knotpushers, suture punches, switching rods, and trocars. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 888.9.